Press releases
- Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
- Axonics Reports First Quarter 2024 Financial Results
- Axonics Stockholders Approve Merger Agreement with Boston Scientific
- Axonics Provides Update on Inter Partes Review Proceedings
- Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
- Axonics Responds to ITC Action by Medtronic
- Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
More ▼
Key statistics
As of last trade Axonics Inc (0I3:DUS) traded at 61.00, -3.17% below its 52-week high of 63.00, set on Apr 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 61.00 |
---|---|
High | 61.50 |
Low | 61.00 |
Bid | 61.00 |
Offer | 63.00 |
Previous close | 61.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 51.02m |
Free float | 50.47m |
P/E (TTM) | -- |
Market cap | 3.44bn USD |
EPS (TTM) | -0.3134 USD |
Data delayed at least 15 minutes, as of May 24 2024 18:30 BST.
More ▼